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Coxsackie viruses have been isolated from patients with a variety of illnesses, 
and  at  times  have  been  particularly associated  with  poliomyelitis, aseptic 
meningitis, epidemic myalgia or pleurodynia (Bornholm disease), and herpan- 
gina (1-11, 30).  In certain  instances, patients with paralytic or non-paralytic 
poliomyelitis have been found to be harboring in their intestinal tract both 
poliomyelitis and Coxsackie viruses (12-15,  3). 
This paper  presents  a  study of the  first  epidemic  of poliomyelitis which 
appeared in Easton, Pennsylvania, during the summer of 1949. It was charac- 
terized by the high ratio of paralytic to non-paralytic cases, by the high propor- 
tion of fatal cases, and by the isolation of both poliomyelitic and C viruses from 
more than half of the patients studied. Twenty-eight strains of C virus were 
isolated and were classified according to antigenic type. 
The Epidemic 
Easton has a population of about 50,000 and is part of a "metropolitan" area 
of about 100,000 population, including Phillipsburg, New Jersey. The Easton 
Hospital serves the entire metropolitan area. 
The history of poliomyelitis in this area, recorded in Fig. 1, indicates that 
prior to 1949 the disease was known to the community but at a low endemic 
rate. During the first half of the summer of 1949, the disease was at its usual 
low level, with only a single case in June and another in July. Explosively the 
epidemic broke in the 2rid week of August (13 cases)  and a high incidence was 
maintained for the subsequent 5 weeks (16,  21,  10, 15, and 18 cases,  respec- 
tively), as shown in Fig. 2. Cases continued to appear regularly through October 
and November (2 to 3 per week), and sporadically into the winter months. All 
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patients diagnosed as suffering from poliomyelitis were admitted to the Easton 
Hospital, where they were classified as paralytic or non-paralytic. In order to 
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be included in the latter category, a patient must have had the symptoms of 
non-paralytic poliomyelitis plus  a  pleocytosis of the  cerebrospinal fluid.  As MELNICK, KAPLAN, ZABIN, CONTRERAS~ AND LARKUM  473 
shown in Fig. 2,  all patients who entered the hospital in consecutive fashion 
between August 26 and September 23 were included for virological and sero- 
logical study. In addition we included for study 4  patients who  entered the 
hospital as suspected cases of poliomyelitis, but in whom the cerebrospinal fluid 
findings were normal. 
Because of the explosive nature of the onset of the epidemic an analysis was 
made of the distribution of cases according to sex in the first and second halves 
TABLE I 
Distribution of Cases According to Sex in the First and Second Halves of the Epidemic 
1st half 
Age  Male  Female  Total  Total cases 
:yf$  • 
0-4 
5-9 
10-14 
15-20 
21+ 
10 
5 
8 
4 
2 
18 
13 
14 
7 
7 
p~r C~nf 
31 
22 
24 
12 
12 
/ 
Total ...................  I  29  30  59 
q 
Per cent ................  i  49  51 
nd half 
Age  Male  Female  Total  Total cases 
y~'$. 
0-4 
5-9 
10-14 
15-20 
21+ 
11 
8 
5 
5 
8 
I 
16 
12 
9 
9 
13 
Total ..................  37  21  59 
Per cent ................  63  37 
per cent 
27 
2O 
15 
15 
22 
of the epidemic. The figures listed in Table I show that a slightly higher percent- 
age of adults was involved in the latter part of the epidemic, and that the usual 
predominance of males over females found during poliomyelitis epidemics was 
absent during the first half of the epidemic. 
Materials and Methods for Virological Studies 
Stools and throat swabblngs were collected daily during the first 3 days of hospitalization. 
The throat swabs were immersed in 0.5 ml. of water. These materials were frozen at  -20°C. 
and kept at this temperature until tested. Serum was obtained on the 1st or 2nd day of hos- 
pitalization, and later samples collected 4 weeks, 12 weeks, and in some instances 18 months 
after onset. Serum was also kept frozen until used. 474  EPIDEMIC OF PARALYTIC POLIOMYELITIS 
The methods used in the preparation and testing of these samples for poliomyelds and C 
viruses, as well as the criteria for positive isolations, have been described in detail previously 
(12, 16, 17). For poliomyelitis virus, one monkey was usually employed and the animal was 
inoculated intracerebrally witha fecal extract which  had been  concentrated and partially 
purified by ultracentrifugation. For C virus, 2 litters of 8 newborn mice each were inoculated 
for each test. 
Neutralization tests were carried out as described  (18) using  a  fixed dose of virus (100 
IDs0) against varying dilutions of serum. 
The viruses were typed in part by cross-neutralization  tests but chiefly by the plate com- 
plement fixation test as adapted to C viruses (19). Antigens were prepared from virus in the 
second or third generation  in mice and run against 9 or 10 prototype sera. 
Neutralizing antibody tests  were  performed  to the Lansing strain in qualitative fashion 
only: 0.2 ml. of undiluted serum was added to 0.2 ml. of virus containing about 200 IDa0 
per 0.03 ml. Following incubation for 1 hour at room temperature, 0.03 ml. was inoculated 
intracerebrally into each of 8 young adult mice. Antibody was regarded as present if 5 or more 
mice survived for 21 days after the inoculation. 
RESULTS 
The  details on  the  virus isolations from  individual patients  are  shown  in 
Table If, with an analysis of the data in Table III. 
Poliomyelitis virus was found in the stools of 27  hospitalized patients in a 
series of 36 who were examined for virus. It was found in 90 per cent (18 of 20) 
of the samples obtained from children under 8 and in 56 per cent (9 of 16)  of 
those 8 years and over. The  throat swabbings of 4  children, 3  of whom gave 
positive stool tests, were  tested for poliomyelitis virus with negative results. 
These results are similar to earlier ones from this laboratory in experiments in 
which virus was sought in the fecal and throat specimens (20, 21). 
C  virus was found in 64 per cent (27  of 42)  of the fecal specimens collected 
in the Ist week of the disease. None of 38 throat swabbings and none of the 30 
serum samples collected at this time yielded virus. During the 4th week of dis- 
ease, fecal samples were collected again, and 22 s~mples from patients yielding 
positive tests in their  ist week samples were tested. Of these 22,  only 3  now 
contained virus in detectable amounts.  During  the acute illness, C  virus was 
found  to be present with  the  same frequency in those under  8  as in  those  8 
years and over. 
In Table IV, the results are shown of the tests on 4 patients who were seen 
at  the  hospital and  then  sent home  because of the  negative findings  in  the 
cerebrospinal fluid.  C  virus was isolated from only one  of these patients,  an 
individual with myalgia. In this instance it was isolated from both  the stool 
and the throat swab. Attempts to detect poliomyelitis virus in these specimens 
were  unsuccessful.  Of  the  28 patients from whom  C  virus was  isolated, it is 
noteworthy that virus was found in the throat only in this single instance. 
Thirty-six patients were studied for both viruses. With  75  per  cent of  the 
patients excreting poliomyelitis virus and 72 per cent C virus, it is obvious that 
a number must have been excreting both agents simultaneously. The extent to MELNICK~  KAPLAN~  ZABIN,  CONTRERAS~  AND  LARKUM  475 
TABLE  II 
Isdation  of Pdiomyditis  and Coxsackle Viruses from Hospitalized Patients* 
•  .  Poliomyelitis  Coxsackie vixus§  ratlen~  viIu,, :~  __ 
Late  stage  Plcoc  I TY~  e  Acute stage  Acute stage (Ist wk.)  (4th wk.) 
NO,  Name  Age  tosff  dis-  "-~  1 
__  I  __  case  Stool  Throat  Stool  ]_~  a,t  i  Ser~  Stool 
2  .  .  --  12/12(9)  1-4-  I 1/14  I -  /  3/6  I 
4  0/8  I  -  I °/14  I -  /  ~/1o  I 
5  A.~I.C.  5  161  NP  "4-  3/23(0)  I  -  ] 0/16  ]  --  [  D/8  I 
6  G.C.  4  ]  12  P  "4-  /  13/13(10  ] +  ] 2/8(  I  --  I  D/8  ]  0/16  ]  -- 
;  M.A.C.  28  2  P  --,--,--  8/8(8)  1%.]  0/15  )]  --  [  I  0/7  -- 
s  tM.-.  I  1  I  75  /NP  /  +  I  l°/14  1-11/lS  I-/1/8(°)i 
10  S. DiG.  9/12  I46  P  --,--,--  17/17(13  ] +  / 0/16  I  --  ]  [)/14  --  0/13  ]  -- 
11  i D.D.  3  52  P  +  7/12(6)  ] %. ] 0/18  [  --  ]  [)/6  --  0/6  ]  -- 
)  12  C.A.F.  /  5  /  t  P  /  "4-  ~ 15/15(13  / "4- I  1/15  t  --  /  !  5/I6(3)  %. 
13  C.F.  13  [  132  /  NP  /  --'--  t  [  12/17(10  ] %.  0/15  [  --  [  0/14  --  0/16  -- 
14  J.M.F.  4  ~  88  [  P  ]  -4-  [  9/9(9)  ] %.  5/17  )[  --  /  1/14(0)  --  3/14(0)  -- 
15  ] J.F.  /  6  /  32  ~ P  /  +  I  ~ 7/7(1)  1%.  0/1~  --  0/13  --  4/7(3)  [ %. 
16  D.G.  /  11  ~  146  ~  NP  [  --  [  11/11(5)  [ %-  0/1~  [  --  [  0/13  --  1/8(0)  [  -- 
17  IA.G-  120  /  62  !P  |  +  /18/18(11)]+  o/1~  [-i  /  I8  J.H.  ]  37  i  209  I  NP  [  %-  /  4/4<4)  I +  [  /  ,/11(o) 
19  K.J.  [  12  [  119  [  V  [  %-  [  5/7(5)  -4-  /  /  I/8(0)  [  - 
20  ] C.K.  3  [  30  ]  P  [  %.  [  ]  12/13(11)[  %.  0/8  [  --  [  I/9(0)  --  8/8(4)  ]  %- 
21  [ R.L.  ] 11  ]  294  [  P  ]  %-  [  [  16/16(13)[  %-  0/8  [  -- [  1/7(0)  --  0/16  { -- 
22  M.L.  8  [  80  /  NP  /  --  /  1/8(0)  I --  0/1~  [  --  /  0/8 
23  r  L.  ~*  [  340  [  P  ]  %-  [  11/11(9)  [ %-  0/8  [  -- ]  0/16  [  -- 
24  N.M.  [  ,211  ,P  ]  %.  i  16/16(15)[  +  0/9  ,  -- ]  13/12(0)/-- 
23  E 3. M.  I  q  13  ]  P  ~  %.  /  [  0/16  [  --  0/11  /  -- ]  0/8 
+ 
r  /  I/ 
30  K.R.  110  P  %.  1/40(0)  i  --  0/8  [  -- /  0/8 
32  F.S.  25  P  %.  18/18(16) 1 +  0/7  /  -  i o/to  -  [  o/8  [  - 
33  D.S.  175  P  %.  14/14(9)  I +  0/7  /  --  i 4/18(0)  --  [  0/12  ]  -- 
34  I J.S.  /  357  [  P  /  +  ]  /  7/7(7)  1%.  0/8  /  -  0/14  -- [  1/9(0)[  -- 
cs  '  :1  38  /P  /  +  /  /0/'8  t-  0/8  i-  /  /  36  M  s.  /  158  /  P  I  I  /  °/8  I-  o/8  I-  o/s 
37  J.A.S.  /  91  /  P  /  +  /  |  0118  l--  0/7  l--  0/8 
39  I  S.S.  t  [  173  [  NP  [  -b  /  /  13/13(12)[  %.  1/6,  [  --  2/8(0)  -- [  0/16  [  -- 
/ 
41  C.T.  62  P  --,--  15/15(11)[  %.  0/6  [  --  Inc. 
42  M  A.T.  395  P  0/8  ]  --  0/6  ]  --  Inc. 
43  F.T.  /  180  /m'/  /  /0/16  ]--  016  ]--  0/10 
44  J.V.  |  95  [  P  [  -[-  [  [  15/15(12)]  %.  0/8  [  -  0/14  -  /  2/I1(0)[  - 
I+/  /,,,,,,,,,,+  ,  t  ,,!ww.  /  /241  1 P  3/17(1 i+  i  - 
P, paralytic poliomyelitis; NP, non-paralytlc  poliomyelitis. 
* These patients were admitted to the Easton Hospital in the period Aug. 26 to Sept. 23, 1949. 
:~  One ncgatlve sign indicates a negative test  in one monkey; a positive sign,  the recovery of poliomyelitis 
virus  in  the  test monkey. 
§ I0/15(9). Of 15 satisfactory  newborn mice in the test,  10 developed paralysis and/or died within 2 weeks 
of inoculation. Of these 10 mlcc, 9 were found with paralysis.  The interpretation of this  tcst  is positive for C 
virus  isolation. The  interpretation  of  all  C  virus  tests is  to  the  right  of  the  column  listing the 
fate  of  the  test mice. --..I  Total  Per I Total  Per I @P ] Per  -{-P' Per I --P  Per  --P  Per  t  No  o, cas°s  .o ,j +p  i centl  +C  [cent I  cent I  cent-C 
........  !__  __1 .... 
Paralytic  28  22  79  21  75  17  ~ 61  !  5  18  4  14  2  7 
Non-paralytic ........  8  5  63  5  63  ]  3  138  2  25  2  25  1  13 
Total ...............  36  27  175  26  72  [20  56  7  I  19  6  16  3  8 
Under 8 yrs.  '  ] 
Paralytic ..........  17  1,5  188  12  71  111  65  4  23  1  6  I  1  /  6 
Non-paralytic ......  3  3  100  1  33  1  33  2  67  0  0  0  0 
Total ..............  20  18  90  13  65  12  /  60  6  30  1  5  /  1  5 
8 yrs. or over 
Paralytic ..........  11 
Non-paralytic ......  5 
Total ..............  16 
2 
9  56 
No. 
9  82 
4  80 
13  81 
6  55  1  9 
2  0  0 
8  1[  6 
3  27 
2  40 
5  31 
9 
20 
13 
P,  poliomyelitis virus; C,  Coxsackie  virus;  q-, presence of virus;  -,  absence of virus. 
TABLE  IV 
Isolation  of Poliomyelitis  and  Coxsackie  Viruses  from  ~ Non-Hospitalized  Patients 
Patient  Poliomyelitis 
virus* 
Cerebro- 
Age  spinal  Symptoms 
fluid 
~s.  cells  per 
C.ftlm. 
24  Stiff neck, head- 
ache 
10  3  Pain  in right 
arm and right 
leg,  spasms 
in back, right 
shoulder,  and 
right leg 
7  4  Headache, vom- 
iting,  diffi- 
culty  in 
walking 
27  Nausea, vomit- 
ing, fever 
Acute stage 
Stool  Throat 
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TABLE  III 
Isolation  of Poliomyelitis  and  Coxsackie  Viruses  from  Hospitalized  Patients  Tested 
for Both Viruses 
Coxsackle virus 
Stool 
0/8  :  - 
i 
i 
14/14(12)[-b 
0/8  - 
! 
2/9 (0)  - 
Acute stage (Ist  wk.) 
Throat 
0/7 
16/16(8)  q- 
i 
i 
i 
i 
0/4 
Inc. 
Serum 
0/8 
1/9(0) 
-  0/8 
i 
i 
Inc. 
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which this was true is shown in Fig. 3 and is given in more detail in Table III, 
in which the results are presented on 28 paralyzed and 8 non-paralyzed pa- 
tients. Both viruses were sought in the samples collected from each of these 36 
patients, and both agents were found in 20  (56 per cent). Only poliomyelitis 
virus was found in 7 (19 per cent), only C virus in 6 (16 per cent), and neither 
virus in 3 (8 per cent). It is worth pointing out that in 4 paralytic patients ex- 
creting C virus, 2 to 3 monkeys were used for each of the poliomyelitis virus 
tests, with negative results. 
.80~ 
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101 - 
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FIG. 3. Poliomyelitis and  Coxsackie virus isolations from paralytic  and non-paralytic 
poliomyelitis patients. -t-P, poliomyelitis virus isolated; -t-C, C virus isolated; -P, polio- 
myelitis virus not isolated; -C, C virus not isolated. 
As noted above poliomyelitis virus was recovered less readily in patients 8 
years and over than in the younger children, but this was not found for C virus. 
Mixed infections of poliomyelitis and C viruses were found to about the same 
degree in both age groups, 12 of 20 (60 per cent) in the younger, and 8 of 16 (50 
per cent) in the older group. Poliomyelitis virus alone was detected more often 
in the younger group, 6 of 20 (30 per cent) as against  1 of 16 (6 per cent) for 
the older group. The reverse was true for the finding of C virus alone, 1 of 20 (5 
per cent ) for the younger, as against 5 of 16 (31 per cent) for the older group. 
In view of the fact that we had only 8 non-paralytic patients in this series, it is 
not possible to evaluate any differences in rates between the paralytic and non- 
paralytic groups. However, it is noteworthy that mixed virus infections were 
found in both groups: 17 of 28 (61 per cent) for those with paralysis and 3 of 8 
(38 per cent) for those without paralysis. 478  EPIDEMIC  OF  PARALYTIC  POLIOMYELITIS 
TABLE  V 
Persistence of Excretion of C Virus in Stools 
No. of  patients in group 
No. of patients yielding 
positive tests for polio- 
myelitis virus in 1st wk. 
specimens 
Isolation of C virus 
1st wk.  4th wk. 
+  --  +  -- 
14  14  14  0  2  12 
8  0  8  0  1  7 
Totals  ..........  22  22  0  3  19 
TABLE VI 
Antibody Responses in Patients from Whom Both Poliomyelitis Virus and C Virus Were Isolated 
Easton-2  Easton-14  Homologous  C  [  Lansln~  Homologous 
Age  Disease  ___  poliomye~tls poliomyelitis 
yrs. 
3 
3 
4 
4 
4 
4 
4 
5 
6 
6 
7 
7 
10 
11 
11 
12 
13 
18 
20 
37 
P 
P 
P 
P 
NP 
P 
P 
P 
P 
P 
P 
P 
P 
P 
NP 
P 
P 
P 
P 
NP 
Cerebro- 
spinal 
fluid 
cells Per 
¢;.mm, 
52 
30 
12 
88 
243 
25 
95 
32 
340 
175 
372 
357 
294 
173 
119 
139 
211 
62 
209 
~on- 
cute  ales- 
:ent 
0  50 
0  250 
0  250 
0  0 
50  50 
0  250 
50  250 
0  5O 
50  250 
0  50 
0  50 
O0  500 
0  250 
0  0 
0  5O 
0  100 
0  250 
0  250 
10  50 
10  250 
~on- 
'ales-  A  te 
.'ent 
0  0 
0 
Oi  0 
250  i  1:i0 
0i  ~5 
250 
250  0 
0  ;0 
250  ~0 
0  0  0 
0  0 
Con-  A  Ct  Cs  vales- 
cent 
50  --  -- 
250  -  -I 
1250  --  --  -- 
250  --  -  -- 
50  --  -  - 
1250  --  - 
+  +  + 
.4-  _  _ 
500  --  -  - 
+  +  + 
0  --  m  -- 
+  +  + 
±  +  + 
+  +  + 
0 
10 
Con- 
vsles- 
270 
A, acute,  C1,  early convalescent serum, 4th week,  C2,  late convalescent serum, 3rd  to 
4th month. 
Attention has been directed to the finding of C  virus more often in the acute 
phase of illness than  later.  The  data  in Table V  show that  the simultaneous 
excretion of poliomyelitis virus did not appear to influence the duration of the 
C  virus carrier  state. Of 14 patients excreting both agents in the  1st week of MELIN"ICK, KAPLAN, ZABIN, CONTRERAS, AND LARKUM  479 
disease,  2  (14 per cent) were still  excreting  C virus 4  weeks after onset.  Of 8 
patients who in the acute phase yielded negative tests for poliomyelitis virus 
and positive  tests for C  virus,  one  (13 per cent)  was still positive in  the 4th 
week. 
Neutralizing Antibodies.--Antibodies  to  the  Easton-2  strain  (isolated  from 
patient 2 listed in Table II) were determined for all patients from whom acute 
TABLE VII 
A ntibody Responses in Patients from Whom C Virus but Not Poliomyelitis Virus Was 
Isolated 
Age, 
yrs. 
9/12 
11 
13 
13 
16 
28 
Cerebro- 
Disease  spinal 
fluid 
P 
NP 
NP 
P 
P 
P 
Esston-2 
ConvR-  Ac~e  lescent 
146  0 
'°  ii  ,0  132  10  10 
62  250 
128  0  .  10 
2  I  o  I  5o 
....  Easton-14  Homologous 
Acu"  Conva- Acut  Cunv~ 
~e  lescent  I  e  le~ent 
0  0  50  500 
1250  1250  10  250 
1250  1250  50  50 
0  0  0  50 
250  250  0  50 
Lansing 
poliomyelitis 
A  C,  C2 
+  +  + 
,+  +  + 
+  +  + 
TABLE VIII 
Antibody Responses in  Patients from  Whom Poliomyelitis Virus  but Not C Virus Was 
Isolated 
Age, 
yrS. 
9/12 
10/12 
5 
6 
11 
Disease 
P 
P 
NP 
P 
P 
Cerebrospinal 
fluid 
13 
38 
161 
110 
Easton-2  Easton-14  Lansing  !  poliomyelitis 
 cuU  le °ot  _Z 
1250  1250 
Acute 
0 
25O 
0 
250 
250 
10 
250  --27_ 
and convalescent sera had been collected. In addition a number of determina- 
tions were carried out for antibodies  to an antigenically different strain,  Eas- 
ton-14  (isolated  from patient  No.  14).  A  selected  group  of  13  patients  was 
studied  for the development of antibodies  to their homologous strain;  i.e., to 
the very strain isolated  from the patient.  The antibody level was determined 
by titrating  the serum  in the presence of a  fixed amount of virus  (100 ID60) 
(18). 
Tables VI to X  show the results of these tests  in relation  to the finding of 
C virus and/or poliomyelitis virus in the specimens from the patient.  In addi- 480  EPIDEMIC  OF  PARALYTIC  POLIOMYELITIS 
tion, we have listed  the results of the Lansing poliomyelitis neutralizing  anti- 
body tests on these patients. For 2 patients on whom we carried out homologous 
strain poliomyelitis antibody tests, these results are also included. As summa- 
rized in Table XI, Easton-2 type infection appeared to be commonplace in these 
patients,  with  19 of 26 patients  from whom C  virus was isolated  showing an 
antibody rise during their disease. Of the 7 patients who failed to show an anti- 
body rise to Easton-2, 4  showed specific rises  to the strain isolated from their 
TABLE IX 
Antibody Responses in  Patients from  Whom neither Poliomyditis  Virus nor C Virus  Was 
Isolated 
Age, 
yrs. 
5 
7 
8 
16 
Disease 
P 
NP 
NP 
P 
Cerebrospinal 
fluid 
394 
4 
80 
79 
Easton-2 
Conva~ 
Acute  lescent 
5~  50 
0 
25~  2500 
Lansing 
Easton-14  poliomyelitis 
Acute 
50 
Conva-  A  Ct 
lescent  __  --  C~. 
50  +  +  - 
±  +  + 
+ 
TABLE X 
Antibody Responses in Patients from Whom C Virus Was 
Poliomyelitis Virus Tests Were Not 
Not Isolated and for Whom 
Done 
Age,  Disease 
yrS. 
2  P 
12  P 
14  P 
16  NP 
24  NP 
27  NP 
Cerebrospina|  Easton-2 
fluid  Conva- 
Acute  lescent 
o  o 
0  0 
395  0  0 
180  0  0 
lO  10 
50  50 
Easton-14 
Conv~t- 
Acute  lescent 
10  10 
Lansing 
poliomyelitis 
I A  Ca  C~ 
[  --  _  _ 
±  +  + 
+  +  + 
i+  +  + 
+  ~  + 
own fecal specimens. In only 3 patients from whom virus was isolated were we 
unable to demonstrate an antibody rise,  even to the patient's own strain.  On 
the other hand,  of 15 patients  in whom C  virus was sought but not isolated, 
only 3  showed rises  to the Easton-2  strain.  16 of the patients  from whom  C 
virus was isolated were also studied  for development of Easton-14 antibodies 
and not one showed such a rise, not even the patient who was the source of the 
Easton-14 strain. 
Lansing Poliomyelitis Neutralization  Tests.--Lansing antibodies  did not in- 
crease in these patients except for one child, who also showed an increase in C MELNICK, KAPLAN~ ZABIN, CONTRERAS, AND LARKU~  481 
virus antibodies. However, Lansing antibodies in this paralytic patient were 
not found until the 3rd month of convalescence. 
The details of the Lansing tests are shown in Table XII. The results for the 
acute, 1 month convalescent, and 3rd to 4th month convalescent sera are listed 
for each patient in chronological order together with the viruses which were 
found in the stools. The distribution of the Lansing tests into negative, positive  , 
and questionable results is shown in Table XIII, which shows that only 5 tests 
gave a questionable result according to the criterion used here (4 or 8 mice de- 
veloping poliomyelitis). Even though the numbers are small, the results on 40 
TABLE  XI 
Demonstrable  Increases in Antibodies 
Coxsackie antibodies  Poliomyelitis antibodies 
Viruses isolated 
Easton-2 
+P +C 
--P +C 
+P --C 
--P -C 
ndP --  C 
+P +C 
--P +C 
+P -C 
-P --C 
ndP -C 
16/20 
3/6 
3/5 
o/4 
0/6 
Easton-14  Homologous  C 
0/11  6/8 
0/5  4/5 
0/1 
0/1 
0/1 
Homologous  Lansing 
poliomyelitis  poliomyelitis 
2/2  1/18 
0/6 
0/5 
0/4 
0/6 
Antibody rise to E-2 or homologous  C virus 
18/20 
5/6 }23/26 
3is} 
0/4  3/15 
0/6 
+P,  poliomyelitis virus isolated,  -t-C,  C  virus isolated,  -P,  polio virus not recovered, 
-C,  C virus not recovered, nd P, no test made for poliomyelitis virus. 
16/20 means that of 20 patients tested, the sera of 16 showed increases in antibodies. 
sera  (see Table XIV)  show a  definite trend, which was reproducible on sera 
collected from the same individuals 1 month and again 3 to 4 months later. Only 
2 of 20 patients under 10 years of age had Lansing antibodies. In the 10  to 14 
age group, 5 of 12 were positive, and this increased to 7 of 8 in the group above 
15. These data indicate that the inhabitants of Easton have had previous expo- 
sure  to Lansing  type virus,  although  spread  of  infection seems  to  be  more 
limited than that found in certain other parts of this country, and especially 
so when compared with results obtained on sera collected from certain Southern 
communities. 
From the neutralization tests with Lansing virus,  it is apparent  that  this 
agent, or one of like antigenic constitution, was not the cause of poliomyelitis TABLE  XII 
Lansing Neutralizing Antibodies in Patients Excreting Poliomyelitis  Virus and~or Cox. 
sackie Virus 
Age 
9/12 
9/12 
10/12 
2 
3 
3 
4 
4 
4 
4 
5 
5 
5 
6 
6 
6 
7 
7 
7 
8 
10 
10 
11 
11 
11 
11 
12 
12 
13 
13 
13 
14 
16 
16 
16 
18 
20 
24 
27 
28 
Patient No. 
10 
25 
35 
40 
11 
20 
6 
14 
28 
4~ 
4 
5 
12 
15 
23 
30 
2 
27 
33 
22 
9 
34 
16 
21 
31 
39 
19 
36 
13 
41 
45 
42 
1 
26 
43 
24 
17 
3 
38 
7 
Poliomyelitis 
VIFUS 
excreted 
÷ 
+ 
+ 
÷ 
+ 
+ 
+ 
÷ 
+ 
+ 
+ 
+ 
÷ 
+ 
÷ 
+ 
+ 
÷ 
+ 
÷ 
+ 
÷ 
c 
vii'us 
excreted 
+ 
+ 
÷ 
+ 
+ 
+ 
÷ 
+ 
+ 
÷ 
+ 
+ 
÷ 
÷ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
÷ 
+ 
Lansing neutralizing antibodies* 
Acute 
u 
+ 
4- 
+ 
+ 
+ 
÷ 
q- 
+ 
+ 
4- 
÷ 
+ 
÷ 
÷ 
Convalescent  Convalescent 
(1 too.)  (3 to 4 mos.) 
+  + 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+  + 
+  + 
+  + 
+  + 
+  + 
4-  + 
+  + 
* +  indicates that of 8  mice inoculated, 5  to 8  survived;  -  indicates 0  to 3  survived; 
:t: indicates 4 survived. 
For tests with patient's strain of poliomyelitis virus, see Table XVII. 
482 MELNICK,  KAPLAN~  ZABIN~  CONTRERAS,  AND  LARKUM  483 
in this epidemic. Our findings are unlike those reported by Steigman and Sabin 
(22). These workers found an increase in Lansing antibody in 6 of 24 patients, 
TABLE  XIII 
Criteria of Lansing Neutralization  Tests and Pattern of Results 
Group 
8/8 
7/8 
6/8 
5/8 
4/8 
3/8 
2/8 
1/8 
0/8 
Total .......................... 
No. of sera in 
each group 
42 
17 
11 
2 
7 
14 
10 
11 
119 
Result 
4- 
+ 
Per cent 
61 
35 
The numerator indicates the number of dead  or paralyzed mice; the denominator indi- 
cates the number of mice inoculated. 
TABLE  XIV 
Lansing Neutralizing Antibodies by Age in Easton Poliomyelitis Patients 
Age group,  yrs  .................................... 
Acute serum: 
No. patients ........................ 
No. positive ........................ 
Positive, per cent .................... 
Convalescent serum: (1 mo.) 
No. patients ........................ 
No. positive ........................ 
Positive, per cent .................... 
Convalescent serum: (3 to 4 mos.) 
No. patients ........................ 
No. positive ........................ 
Positive, per cent .................... 
O-4 
10 
0 
0 
5-9 
10 
2 
20 
I0 
2 
20 
10 
2 
20 
10-14 
12 
5 
42 
12 
5 
42 
11 
5 
45 
15-20 
5 
4 
80 
5 
4 
80 
5 
4 
80 
2t+ 
3 
3 
100 
3 
3 
100 
3 
3 
100 
particularly if sera obtained 3  months  after convalescence were compared with 
acute specimens. In the present study only one of the Easton patients developed 
such an increase even when sera obtained as late as 4  months  after onset were 484  EPIDEMIC  OF  PARALYTIC  POLIOMYELITIS 
tested.  Our results are in accord with  those reported from other laboratories 
(23, 24.). 
When the age distribution pattern of 2  C  viruses is tabulated together with 
the Lansing results, as in Table XV, it is seen that infection with Easton-2 and 
TABLE XV 
Development of Neutralizing .4 ntibodles to Lansing Poliomyelitis Virus and to Easton-2 and 
Easton-14 Coxsackie Viruses in D~fferent Age Groups 
Patients in  Lansing neutralizing  Easton-2 neutralizing  Easton-14  neutralizing 
epidemic  antibodies  antibodies  antibodies 
Age, 
yrS. 
0-4 
5-9 
10-14 
15-20 
21+ 
34 
25 
23 
16 
19 
Acute sera  Convalescent 
sera 
NO.  c~n~  NO.  C~ 
tested  tested 
10  0  9  0 
10  20~  10  20 
12  42  12  42 
5  80  5  80 
3  100  3  100 
Acute sera  Convalescent 
sera 
tested  tested 
10  30  10  70 
9  33  9  67 
9  44  9  89 
5  20  5  60 
4  75  4  100 
Acute sera  ] Convalescentsera 
i 
No.  I Per I  No.  i Per 
tested  c~t  tested  cent  + 
r  29  !  7  29 
;  80  5  80 
;  67,  3  67 
1  0'i  1  0 
3  ,67  3  67  ! 
TABLE XVI 
Family D(fcztlon with Poliomyelitis and Coxsackie Virtues 
Age,  Cerebrosplnal 
~rs.  _  ].  fluid 
G.C .................  4  12 
A. M. C  ...............  5  161 
Disease 
P 
NP 
Poliomyelitis 
virus 
+ 
+ 
C wrus 
+ 
Neutra]izing antibody response 
G,C,  A.M.C. 
Virus used in neutralization test 
Easton-2 ....................... 
Easton-14 ...................... 
Easton-6 (G. C.) ................ 
Lansing poliomyelitis  ............ 
1st wk.  4th wk. 
250 
0 
250 
0 
1st wk. 
0 
1250 
0 
0 
4th wk. 
250 
1250 
250 
0 
Easton-14 C  viruses took place earlier, and that of these three antibodies only 
those to Easton-2 increased significantly during the epidemic. 
Family  Infection  with  Both  Viruses.--Two  patients  were  admitted  to  the 
hospital from the same family, with G. C., aged 4, diagnosed as paralytic, and 
A.  M.  C.,  aged  5,  as  non-paralytic poliomyelitis (as  shown  in  Table  XVI). 
Poliomyelitis virus was isolated from both, and C virus only from the paralytic lVrELNICK, KAPLAN,  ZABIN,  CONTRERAS,  AND  LARKIY~  485 
child. The neutralizing antibody study, however, showed that C virus infection 
with the E-2 type occurred in both children at the time of their illness,  for both 
had a  serum titer of zero in the acute phase serum and a  titer of 250 in the 
serum collected 4 weeks later. These levels were also found with the Easton-6 
strain  (which had been isolated from G. C.) as the virus in the neutralization 
test. and subsequent work showed that the E-2 and Easton-6 strains are anti- 
genically related.  However, when  the  unrelated  Easton-14  strain  was  used, 
G. C.'s acute and convalescent sera were negative, while  A. M.  C.'s  two sera 
contained the same high level of 1250,  indicating previous infection with an 
E-14 type. 
Dua.l Antibody Studies in Patients Simultaneously Excreting C and Poliomye- 
litis  Virus.--Two patients (Nos. 11 and 12) with paralytic poliomyelitis were 
studied in detail using as virus in the neutralization test the patient's own stool. 
Each serum-virus mixture was inoculated into 3 monkeys to test for poliomye- 
litis antibodies and into 2 litters of newborn mice to test for C virus antibodies. 
In addition, for the C virus antibody tests, the mouse passage virus was used. 
Sera were used in serial threefold dilutions as shown in Table XVII, which also 
gives the results of these tests. 
Similar findings were obtained on both patients. Antibodies were negligible 
or present in low titer on the 3rd or 4th day of disease and these had increased 
significantly for both poliomyelitis and C viruses by the 32nd day. The result 
with the mouse passage C virus was similar to that found with the C virus in 
the patient's stool. 
Typing of C Viruses Isolated during the Epidemic.--From the frequent anti- 
body rise to Easton-2 strain (Table XI), we suspected that this strain would be 
the one most commonly obtained from the patients during this outbreak. Also 
in view of the fact that some patients failed to produce antibodies to Easton-2 
and Easton-14 types but did to their homologous strain, we had reason to be- 
lieve that other types were also present in Easton in 1949. A systematic inves- 
tigation was made by the complement fixation test (19) of 28 strains isolated from 
as many patients. The details of the typing carried out on these and a number 
of other strains isolated from various parts of this country and abroad will be 
described elsewhere. For the present purposes, it is sufficient to point out that 
the plate complement fixation test was used with antigens being made from 
each of the 28 strains. Antigen was prepared by inoculation of newborn mice 
(less  than 24 hours old) with 10  --I suspensions of infected routine torsos, and 
harvesting  the recipient mice 48 hours later regardless of whether they had 
developed disease.  These antigens  were run  against  the  following prototype 
sera:  Texas-l,  Conn.-5,  Ohio-l,  Easton-2  (Albany type  1),  Albany  type 2,1 
Albany type 3,  Nancy, Easton-10, and Easton-14.  Certain strains,  including 
We wish to acknowledge Dr. Gilbert Dalldorf's kindness in sending us the three strains 
which he isolated in Albany, and which he designated as types 1, 2, and 3. 486  EPIDEMIC  OF  PARALYTIC POLIOMYELITIS 
all those used as prototypes, were also run against serum to Alaska-5 type. The 
list  includes  three  types  which  were  encountered  in  Easton,  one  of  which, 
Easton-2, was found  to be related  to Albany type 1 and two of which, Easton- 
10 and Easton-14,  were found to be hitherto  unknown  types. This was estab- 
lished by the fact that Easton-10  and Easton-14  antigens failed to react with 
the  other  prototype  sera  and  conversely  that  Easton-10  and  Easton-14  sera 
TABLE XVII 
Simultaneous Development  of A ntibodies to Poliomyelitis Virus and C Virus 
Pati- 
ent 
No. 
11 
12 
,ay of 
isease 
erum 
col- 
.*cted 
3 
32 
3 
32 
4 
32 
4 
32 
IDlo i 
tO pe 
ce~t s~ 
peUSlO 
of 
patienl 
stool 
1 
10 
100 
10 
Final seruth dilutions 
1:10  I 1:30  11:90  [1:270 
C virus: in mice 
0/8  4/15(3)  [ 
0/15  0/8  I 0/14  3/12(3) 
Poliomyelitis virus: in monkeys 
0/3  I  2/3 
0/3  o/3  0/3  0/3 
C virus: in mice 
3/12(2)t7/14(7)1  4/7(3) 
0/6  0/6  0/14 
Poliomyelitis virus: in monkeys 
1/3  ,i  3/3  [ 
0/3  10/3  1/3  1/3 
ttlon  of 
loses of 
C  virus 
Dilution 
of serum 
protect- 
ing 50 
per cent 
of 
animals 
0 
150 
0 
110 
Denominator indicates  the number of animals used  per serum  dilution.  The  numerator 
indicates  the number of animals with disease. The number in parentheses indicates  the num- 
ber of mice with observable paralysis. All monkeys with disease showed some degree of paraly- 
sis (mild to severe) and all sick animals had typical poliomyelitic  lesions in the spinal cord. 
No CNS lesions were found in monkeys which failed to develop paralysis. 
reacted  specifically with  Easton-10  and  Easton-14  antigens  respectively,  and 
not with the other prototype antigens. 
It was found of the 28 strains tested,  that 24 were related to Easton-2,  2 to 
Easton-14,  1 to Easton-10, and 1 to Nancy. Of the 24 patients who were found 
infected  with  Easton-2  type virus,  22  were  studied  to  determine  whether  or 
not  they showed a  rise in neutralizing  antibodies  to the Easton-2  strain.  It is 
noteworthy  that  18 of the  22 developed Easton-2  antibodies at the time when M_ELNICK~ KAPLAN.  ZABIN~  CONTRERAS~  AND  LARKUM  487 
an Easton-2 type of virus was being excreted. Thirteen of these patients were 
also studied for Easton-14 neutralizing antibodies and none showed a rise. Con- 
versely, 4 patients were found infected with one of the following types: Nancy, 
TABLE  XVIII 
Classification by Complement Fixation Reaction of 28 Strains Isolated during Easton 1949 
Epidemic, and Correlation with Rise in Neutralizing Antibodies 
Type of strain by 
complement fixation 
Easton-2 
(Albany-l) 
Easton-14 
Easton-10 
Nancy 
Patient No. 
11 
20 
6 
32 
44 
28 
12 
15 
23 
2 
33 
34 
21 
39 
19 
13 
45 
41 
1 
26 
24 
7 
47 
18 
14 
9 
10 
16 
Age, 
yrs. 
3 
3 
4 
4 
4 
4 
5 
6 
6 
7 
7 
10 
11 
11 
12 
13 
13 
13 
16 
16 
18 
28 
28 
37 
4 
10 
9/12 
11 
Type of  Rise in neutralizing antibodies 
disease 
p$ 
P 
P 
P 
P 
NP 
P 
P 
P 
P 
P 
P 
P 
NP 
P 
NP 
P 
P 
P 
P 
P 
P 
P 
NP 
P 
Myalgia 
P 
NP 
iEastono2 
+ 
+ 
+ 
+ 
+ 
0 
+ 
+ 
+ 
+ 
+ 
+ 
0 
+ 
+ 
0 
+ 
nd 
+ 
0 
+ 
+ 
nd 
+ 
0 
nd 
Easton-  14 
0 
0 
0 
nd 
0 
0 
0 
0 
nd 
0 
nd 
nd 
0 
nd 
nd 
0 
nd 
nd 
0 
nd 
nd 
0 
nd 
0 
0 
nd 
Homologous 
+ 
nd 
+ 
nd 
nd 
+ 
+ 
+ 
nd 
+ 
nd 
nd 
0 
nd 
nd 
0 
nd 
nd 
+ 
nd 
nd 
+ 
nd 
nd 
0 
nd 
+ 
+ 
* P, paralytic; NP, non-paralytic  poliomyelitis; nd, not done. 
Easton-10,  or  Easton-14.  Three  of  these  patients  were  studied  for  Easton-2 
and  Easton-14 antibodies and none responded with antibodies to these types, 
while 2 of 3 tested showed a  rise in neutralizing antibodies to their homologous 
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In Table XVIII we have grouped the Easton patients according to the type 
of strain isolated, development of neutralizing antibodies, and clinical illness. 
RECAPITULATION 
1.  Easton,  Pennsylvania, and  its  environs suffered their first known epi- 
demic of poliomyelitis in 1949, an outbreak characterized by a high pr6portion 
of paralytic to non-paralytic cases and by the isolation of both poliomyelitis 
and Coxsackie, or C,  viruses from more than half the patients studied. All 
patients  who  entered  the  hospital  during  the  height of  the  epidemic  were 
included for virological and serological  study. 
2.  Poliomyelitis virus was found in the stools of 27 patients of a  series of 
36  who were examined (75  per  cent).  Throat swabbings of 4  children, 3  of 
whom gave positive stool tests, were tested for poliomyelitis virus with negative 
results. 
3.  C  virus was found in 27  of 42  (64 per  cent)  fecal specimens collected 
during the 1st week of disease. None of 38 throat swabbings and none of 30 
serum samples collected at this time yielded virus. 
4.  During the 4th week of disease, fecal samples were again collected. Of 
22 samples from patients yielding positive tests in their early sample, only 3 
specimens were positive. 
5.  Of 4 patients with a  minor disease  (not  poliomyelitis according to our 
criteria), one with a diagnosis of myalgia yielded C virus in specimens collected 
from the throat as well as from the intestines. Attempts to detect poliomyelitis 
virus in these specimens were unsuccessful. 
6.  Both poliomyelitis and C virus were sought in the fecal samples collected 
from each of 36 patients (28 paralytic and 8 non-paralytic). Both agents were 
found in 20 (56 per cent), poliomyelitis virus alone in 7 (19 per cent), C virus 
alone in 6  (16 per cent),  and  neither virus in 3  (8 per cent). Dual virus in- 
fections were found  in  both paralytic and non-paralytic groups: 17 of 28  (61 
per cent) for the former and 3 of 8 (38 per cent) for the latter. 
7.  Twenty-eight  strains  isolated  from  as  many  patients  were  classified 
according to antigenic type. Twenty-four were found to belong to one antigenic 
type, Easton-2  (related  to  the  Albany type  1 virus);  1  to  the Nancy type 
virus; and 3 to two hitherto unknown types (2 to Easton-14 and one to Easton- 
10). None of the strains reacted with the following prototypes: Conn.-5, Ohio-l, 
Albany type 2, Albany type 3,  Alaska-5, and Texas-1. 
8.  Of 22 patients infected with the Easton-2 type, 18 developed Easton-2 
neutralizing antibodies. Thirteen of these patients were also studied for Easton- 
14 antibodies and none showed a rise. Of 3 patients from whom a C virus other 
than Easton-2 was isolated and who did not respond with Easton-2 antibodies, 
2 developed antibodies to the strain isolated from their fecal specimens. 
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tions made, 23 showed a  rise either to the Easton-2 or the homologous type 
antibody. On the other hand, of 15 patients from whom C virus was not iso- 
lated, only 3 showed rises to the Easton-2 strain. 
10.  With  the exception of one patient,  the presence of Lansing antibodies 
did not increase; these tests were carried out on acute, 1 month convalescent, 
and 3rd to 4th month convalescent sera. 
11.  Apparently Lansing  type  virus  had  been  present  in  Easton  prior  to 
this epidemic. While only 2 of 20 patients under 10 had Lansing antibodies, 
these increased to 5 of 12 in the 10 to 14 age group and to 7 of 8 in the group 
above 15. Infection with Easton-2 and Easton-14 viruses seems to take  place 
at an earlier age than was the case for Lansing virus. 
12.  A family infection occurred in which 2 members were infected with both 
poliomyelitis and C viruses. 
13.  Two patients with paralytic poliomyelitis were studied for the develop- 
ment  of both poliomyelitis and  C  virus antibodies.  Using  the neutralization 
test, a simultaneous rise in antibodies against both agents was observed. 
DISCUSSION 
The simultaneous presence of. poliomyelitis virus and  C  virus  in patients 
has been observed by Rhodes (13) and Dalldorf (3) as well as in our own labora- 
tory (5,  12, 14, 15).  In addition we have also found that both viruses may be 
found in the same specimen of sewage or flies (5,  25).  The present study is 
unique in that over half of the poliomyelitis patients examined, particularly 
those with the paralytic form of the disease, were found to be excreting both 
viruses. The rise in antibodies during convalescence showed that most of the 
patients  excreting C  virus had  been infected with  this virus at  the  time of 
their acute onset.  These patients  undoubtedly also had  an antibody rise  to 
the poliomyelitis type with  which  they were infected. However, because at 
the present time monkeys are required for these tests, we carried them out in 
only 2 patients: both showed a rise in poliomyelitis antibodies which paralleled 
the rise in C virus antibodies. Thus patients who excrete both viruses during 
acute paralytic disease may develop antibodies against both agents. 
In the main, these patients were infected with one type of C virus, Easton-2, 
which is related to Albany type 1 of Dalldorf. If infection with this antigenic 
type in any way influenced the development of paralysis in these patients, it 
is pertinent to  compare this  C  virus type with  another which  was  isolated 
during an epidemic of mild poliomyelitis. In the latter epidemic which occurred 
in Ohio in 1947, both poliomyelitis virus and C virus were also isolated from 
the same patient. The epidemic was characterized by high incidence of minor 
illnesses  ("summer grippe").  From  3  patients  in  this  epidemic,  the  Ohio-1 
type of C virus was isolated and all 3 developed Ohio-1 antibodies (12). Two 
of these patients had been shown previously to have been excreting poliomyelitis 490  EPIDEMIC  OF PARALYTIC  POLIOMYELITIS 
virus in the identical fecal specimen (26).  Other patients with non-paralytic 
illnesses in Ohio were found to be excreting poliomyelitis virus and the Conn.- 
5 type of C virus. In Connecticut during the summer of 1948, patients with 
aseptic meningitis (from whom we were unable to obtain poliomyelitis virus) 
were  also  found infected with  the  Conn.-5  type  (6).  The  Easton-2  type of 
virus (the one isolated most often from paralytic patients during the Easton 
epidemic)  is  not  only antigenically different from  the  Ohio-1  and  Conn.-5 
viruses, but has different biological properties. In the infant mouse Easton-2 
virus produces lesions restricted to the muscle (so-called group A of Dalldorf) 
while  Ohio-1  and  Conn.-5  viruses  produce  lesions  in  other  tissues  as  well, 
particularly in the fat pads, brain, and pancreas (group B). A histopathological 
description of these types can be found in another publication (27). The ques- 
tion may be raised as to whether in a patient infected with poliomyelitis virus, 
simultaneous infection with art Easton-2 type virus tips the balance in favor 
of paralysis, while infection with an Ohio-1 type virus (or Conn.-5 type) limits 
the spread of poliomyelitis virus within the body. Although our attempts (5) 
to demonstrate either enhancement of or interference with poliomyelitis infec- 
tion in mice or primates have not yielded positive results, Dalldorf (28) has re- 
ported some success with certain C viruses interfering with poliomyelitis  virus. 
The  epidemic in  Easton  was  characterized  by  an  abrupt  onset  (Fig.  2). 
During the first half of the epidemic the usual preponderance of males over 
females was not present, although the ratio of male to female patients in the 
second half of the epidemic was 1.7 to 1 (Table I). These observations suggest 
that something unusual occurred in Easton when the epidemic flared up, and 
the possibility must be considered that this was an outbreak of C  virus in- 
fection in the community. It is noteworthy that in 1949 poliomyelitis had a 
higher prevalence than usual in New York City (29), but the outbreak was of 
a much milder nature than that which occurred in Easton. In another study 
from this laboratory  (15),  20 representative paralytic and non-paralytic pa- 
tients,  suspected  of  having  poliomyelitis during  the  New  York  City  1949 
outbreak, were examined for C  virus. Virus,  also belonging to the Easton-2 
type, was recovered from the stools of 2 of these patients, both paralytic cases. 
Both patients were found to be excreting poliomyelitis virus together with C 
virus. Thus in the same year in different epidemics, Easton-2 type C virus and 
poliomyelitis virus were found associated in the same patients with paralytic 
poliomyelitis. However, in Easton where the incidence of paralytic poliomyelitis 
was high, the recoveries of Easton-2 virus were also high. In New York City 
with  a  lower  incidence of paralytic poliomyelitis, Easton-2  virus,  although 
present, was found less frequently. 
S~RY 
The first known epidemic of poliomyelitis in Easton, Pennsylvania, occurred 
in 1949, and was unusual in the high proportion of paralytic to non-paralytic MELNICK, KAPLAN, ZABIN', CONTRERAS, AND  LARKUM  491 
cases. Both poliomyelitis and Cosxackie, or C, viruses were isolated from more 
than half the patients studied during the acute stage of the disease. One month 
later C virus was only occasionally recovered. Classification of the 28 strains 
of C virus which were isolated revealed that 24 belonged to one antigenic type, 
Easton-2  (related to Albany type 1 virus). 
Patients from whom C virus was isolated showed a rise during convalescence 
to  the  Easton-2  or homologous type antibody.  Two patients  with paralytic 
poliomyelitis were studied for the quantitative development of antibodies to 
the poliomyelitis virus and to the C virus found in their stools. Using the neu- 
tralization test in monkeys and in newborn mice, respectively, a simultaneous 
rise in antibodies to both agents was observed. 
The  situation  at  present  can  be  summarized  as  follows  :--Poliomyelitis 
virus or C virus may produce infection in man,  with a  specific antibody re- 
sponse.  Both agents  may be  carried, particularly  in  the  intestines,  without 
causing any serious illness and healthy carrier states have been observed for 
each. Both viruses can be found in nature in flies and in sewage. However there 
has been no evidence to suggest that these two viruses bear a  relationship to 
each other, even when isolated from the same patient. Thus, when both viruses 
are found in a  patient with paralysis, it is not yet possible to say with any 
degree of accuracy to what extent each is responsible in the over-all pattern 
of the disease. How frequently dual infections of this nature may occur remains 
for future investigations to determine. Certainly all cases of poliomyelitis are 
not complicated by a  superimposed infection with a  C  virus.  However, this 
will have to be one more item to consider in epidemic poliomyelitis. 
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